FDA "cosmeceutical" regulatory class with premarket approval advocated by J&J researcher.
This article was originally published in The Rose Sheet
Executive Summary
FDA "COSMECEUTICAL" REGULATORY SCHEME WITH PREMARKET APPROVAL ADVOCATED by Johnson & Johnson Consumer Products Worldwide VP-Research & Development Geert Cauwenbergh at a 1996 HBA Global Expo symposium on the future of skin care in New York City June 3. Predicting that FDA will address the regulatory issue of "cosmeceuticals" in the next five years, Cauwenbergh suggested that three "key" requirements be established as part of a cosmeceutical approval process.